Unique ID issued by UMIN | UMIN000001788 |
---|---|
Receipt number | R000002158 |
Scientific Title | Achieved timing of nocturnal BP dip by negative sodium balance with diuretics in CKD: comparison between diuretics alone and its combination with ARB. |
Date of disclosure of the study information | 2009/03/24 |
Last modified on | 2015/09/22 09:08:59 |
Achieved timing of nocturnal BP dip by negative sodium balance with diuretics in CKD: comparison between diuretics alone and its combination with ARB.
Achieved timing of nocturnal BP dip by negative sodium balance.
Achieved timing of nocturnal BP dip by negative sodium balance with diuretics in CKD: comparison between diuretics alone and its combination with ARB.
Achieved timing of nocturnal BP dip by negative sodium balance.
Japan |
Chronic kidney disease (CKD)
Nephrology |
Others
NO
Time courses of nocturnal BP dip achieved by negative sodium balance will be compared with diuretics alone or its combination with ARB.
Pharmacodynamics
Confirmatory
Pragmatic
Not applicable
Duration in days since diuretics alone, or in combination with ARB, are administered until nocturnal BP becomes lower than 90% of daytime averages.
Changes in the night/day ratio of urinary albumin excretion, 24-h BP, glomerular filtration rate, daily urinary albumin excretion, HbA1c, and serum uric acid, or any adverse event
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
1) Pre-intervention, 2) diuretics (HCTZ 12.5mg) once in the morning for a week, and then, 3) combination of diuretics (HCTZ 12.5mg) with angiotensin II blocker (losartan 50mg) once in the morning for a week
15 | years-old | <= |
Not applicable |
Male and Female
Eligibility criteria include the following: 15 years of age or older; hospitalized in Nagoya City University hospital; diagnosed as having chronic kidney disease (CKD) based on K/DOQI criteria (either kidney damage or glomerular filtration of <60 mL/min/1.73m2 for 3 months or more); and written informed consent was obtained.
Exclusion criteria are as follows; use of inhibitors of renin-angiotensin system or diuretics 1 month before enrollment; specific contraindication to a study drug; HbA1c of 9.0 % or above; serious liver damage (GOT >100, or GPT >85); secondary hypertension; accelerated or malignant hypertension (progressive renal dysfunction with diastolic BP of >120-130 mmHg); serious congestive heart failure, coronary heart disease, arrhythmia, or systemic diseases; presence or possibility of pregnancy; or any reason for ineligibility suggested by the attending doctor.
5
1st name | |
Middle name | |
Last name | Michio Fukuda |
Nagoya City University Graduate School of Medical Sciences
Department of Cardio-Renal Medicine and Hypertension
Mizuho-ku, Nagoya 467-8601, Japan
052-853-8221
m-fukuda@med.nagoya-cu.ac.jp
1st name | |
Middle name | |
Last name | Michio Fukuda |
Nagoya City University Graduate School of Medical Sciences
Department of Cardio-Renal Medicine and Hypertension
Mizuho-ku, Nagoya 467-8601, Japan
052-853-8221
m-fukuda@med.nagoya-cu.ac.jp
Department of Cardio-Renal Medicine and Hypertension, Nagoya City University Graduate School of Medical Sciences
None
Self funding
NO
2009 | Year | 03 | Month | 24 | Day |
Unpublished
the results from interim analysis was reported in the medical conferences (2014JSN, JSH).
under reporting the dissertation
No longer recruiting
2009 | Year | 02 | Month | 09 | Day |
2009 | Year | 03 | Month | 01 | Day |
2015 | Year | 12 | Month | 31 | Day |
2015 | Year | 12 | Month | 31 | Day |
2009 | Year | 03 | Month | 22 | Day |
2015 | Year | 09 | Month | 22 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002158
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |